Gunderson Dettmer 2024 Portfolio Investments and Fund Formations*

Gunderson Dettmer is the recognized leader in the venture capital and growth equity fund formation marketplace. In the first three quarters of 2024, Gunderson Dettmer represented investors in over 696 portfolio investments valued at more than $84 billion and helped close 125 fund formations valued at more than $8 billion to be invested in high-growth, emerging technology companies across markets and stages. 

Since 2022, the firm has negotiated 3270 portfolio investments with an overall total of $191 billion and has represented clients in the formations of funds valuing more than $192 billion in capital investments.

*This fund formations and portfolio investments list is exclusive to firms that have made public announcements and is not comprehensive of all work completed recently.

Selection of Portfolio Investments in Companies in Q3

Bicycle Capital Leads US$55M Series B of Brazil-based Cayena
Bicycle Capital leads the US$55 million Series B financing of Cayena, a Brazilian startup that helps transactions between suppliers and buyers in the wholesale food sector

Mayfield Leads $25M Series B Financing of Orb
Gunderson Dettmer client Mayfield leads the $25 million Series B financing of Orb, a billing software for finance organizations

Mayfield Leads $28M Series B of TeamBridge
Mayfield leads the $28 million Series B financing of TeamBridge, a workforce operating system built by former Uber product and design leaders

Gunderson Dettmer Represents Investors in Glean’s $260M Series E Financing
Altimeter, DST Global, Craft Ventures and Coatue invest in the $260 million Series E financing of Glean, an AI enterprise search startup

Gunderson Dettmer Represents Lead Investors in Sakana AI $100M Series A
Lux Capital, Khosla Ventures and New Enterprise Associates lead the $100 million Series A financing of Sakana AI, a Japan-based AI research and development company

Regeneron Ventures Invests in Cell Therapy Company ArsenalBio
Regeneron Ventures participates in the $325 million Series C financing of Arsenal Biosciences to drive further innovation in developing tools and processes for identifying new candidate cell therapies

Lux Capital Makes First Brazil-Based Investment by Leading the $4M Seed Financing of Magie
Gunderson Dettmer client Lux Capital led the $4 million Seed financing of Magie, a Brazil-based AI-powered financial assistant 

Viking Global Invests in BridgeBio Pharma’s Offshoot GondolaBio
Viking Global announces its investment in GondolaBio, a newly formed joint venture carved out from BridgeBio Pharma

A16z Leads $175M Series B Financing of Saronic
Gunderson Dettmer client A16z led the $175 million Series B financing of defense technology leader, Saronic 

Khosla Ventures Leads $142M Series D Financing of Aven
Khosla Ventures led the $142 million Series D financing of Aven, a technology company offering consumer credit cards backed by home equity

Dalus Capital Invests in Mexican Healthtech Eden
Dalus Capital participates in the $10 million financing of Eden, a healthtech specializing in generative AI for medical imaging and clinical diagnostics

Dragoneer Investment Group Investing up to $200M in Tekion
Gunderson Dettmer client Dragoneer Investment Group announces its up to $200 million growth equity financing of Tekion to improve the automotive retail ecosystem

Greenoaks Invests in Defense AI Company Helsing
Greenoaks participates in the $487 million Series C financing of Helsing, a defense AI company

Selection of Fund Formations Through Q3

DCVC Bio Announces $400M Fund Formation
DCVC Bio, a biotechnology venture fund investing in scientific breakthroughs by top innovators, announces the formation of its $400 million fund, DCVC Bio III

Patron Announces $100M Fund II to Back Seed Stage Founders Building for the Next Generation
Patron announces its $100 million Patron Fund II, which will be used to back seed-stage founders building for the next generation of consumers

Kleiner Perkins Announces Two New Funds Totaling $2B
Kleiner Perkins announces KP21, an $825M fund to back early stage companies, and KP Select III, a $1.2B fund to back high inflection investments

Austin-based Ironspring Ventures Announced $100M Fund II
Ironspring Ventures announces the formation of Ironspring Fund II, a $100 million fund, to invest in 20 startups

The Engine Ventures Announces $398M Fund III to Invest in Tough Tech
The Engine Ventures announces the formation of Fund III to invest in the planet’s most challenging problems and create a positive impact on society

Companyon Ventures Announces Fund III
Companyon Ventures announces the formation of its third investment fund to invest in 14 to 16 post-seed, pre-Series A B2B software companies

Eniac Ventures Raises $220M Across Two Fund Formations
Seed-stage firm, Eniac Ventures, announces its new $160M Eniac Ventures VI seed stage fund, as well as its existing $60M Eniac Select I opportunity fund.

Evolution Equity Partners Raises $1.1B for Cybersecurity Investments
Evolution Equity Partners announces Evolution Technology Fund III to back visionary entrepreneurs building next generation cybersecurity companies that safeguard the digital world in the United States, United Kingdom, the EU and Israel.

Boston-Based Underscore VC Announces $58M Fund III
Underscore VC, a Boston-based VC firm that invests in bold B2B software entrepreneurs at pre-Seed and Seed stages, announced its $58 million fund formation

Artemis Fund Announces Fund II
Artemis Fund announces the formation of its $36 million second fund to invest in female and diverse founders in fintech, commerce and care 

TCG Labs-Soleil Announces Over $400M Inaugural Fund Formation
TCG Labs-Soleil announces its ingaufural fund of over $400M, TCG Labs Fund I and Soileil, to invest in companies focused on therapeutic solutions for patients facing serious diseases